跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DULOXETINE ALEMBIC duloxetine (as hydrochloride) 30 mg enteric capsule blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
DULOXETINE ALEMBIC duloxetine (as hydrochloride) 30 mg enteric capsule blister pack
Approved
STANDARD
DULOXETINE ALEMBIC duloxetine (as hydrochloride) 30 mg enteric capsule blister pack
Alembic Pharmaceuticals Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
88e6f5bd1aed6d71
Company
Alembic Pharmaceuticals Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
88e6f5bd1aed6d71
Product Name
DULOXETINE ALEMBIC duloxetine (as hydrochloride) 30 mg enteric capsule blister pack
Artg Id
199258
Artg Name
DULOXETINE ALEMBIC duloxetine (as hydrochloride) 30 mg enteric capsule blister pack
Sponsor
Alembic Pharmaceuticals Australia Pty Ltd
Company Detail Path
/organization/alembic-pharmaceuticals-australia-pty-ltd
Artg Date
2013-06-14
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
88e6f5bd1aed6d71
Type
Standard
Back to TGA Approvals
